CN Stock MarketDetailed Quotes

688076 Jiangsu Sinopep-Allsino Biopharmaceutical

Watchlist
  • 56.60
  • -0.55-0.96%
Market Closed May 28 15:00 CST
12.07BMarket Cap57.93P/E (TTM)

About Jiangsu Sinopep-Allsino Biopharmaceutical Company

The company is a market-oriented, R&D and innovation-driven biomedical enterprise focusing on R&D, production and sales of polypeptide drugs and small molecule chemical drugs. The company is committed to solving technical bottlenecks and optimizing process paths in drug development and production through technological innovation, building a whole industry chain from advanced pharmaceutical intermediates and APIs to formulations to provide high-quality, efficient, green and low-cost pharmaceutical products and services to the global market. The company is a biomedical enterprise focusing on the combination of independent research and development of polypeptide drugs and small molecule chemicals with customized R&D and production. The company's main products include customized product business and self-selected product business.

Company Profile

Short Name-A诺泰生物
Company NameJiangsu Sinopep-Allsino Biopharmaceutical Co., Ltd.
Listing DateMay 20, 2021
Issue Price15.57
Shares Offered53.30M share(s)
FoundedApr 3, 2009
Chairmanziquan tong
Legal Representativeziquan tong
General Managerziquan tong
Secretaryhua zhou
Employees1545
ProvinceJiang Su Sheng
Phone0571-86297893
Office AddressRoom 1201, Block E, Science Park, Hangzhou Normal University, No. 1378 Wenyi West Road, Yuhang District, Hangzhou
Zip Code311121
Registered AddressNo. 28, Linpu Road, Lianyungang Economic and Technological Development Zone, Jiangsu
Fax0571-86298631
Emailir@sinopep.com
Business License913207006871974358
BusinessProduction of freeze-dried powder injections, small-volume injections (including non-final sterilization), APIs, tablets, hard capsules, health products, and medical devices (all operated according to license approval); research and development of pharmaceutical technology and biotechnology; production of pharmaceutical intermediates and peptide intermediates (with the exception of products involving special approval such as pharmaceuticals, health products, food, feed, etc.); production and sale of fine chemical products (other than hazardous chemicals); own and agent import and export business of various types of goods and technologies, with the exception of goods and technologies restricted or prohibited from being imported by national companies. (For projects requiring approval according to law, business activities can only be carried out after approval by the relevant departments)

Company Executives

  • Name
  • Position
  • Salary
  • yan jiang
  • directors
  • 150.00K
  • guoqiang shi
  • directors,Deputy General Manager,Core technical personnel,Deputy Director of the Research Institute
  • 1.98M
  • yuming pan
  • directors
  • --
  • ziquan tong
  • directors,Core technical personnel
  • 1.64M
  • dezhong zhao
  • directors
  • --
  • deyi zhao
  • directors
  • 458.80K
  • fuqiang jin
  • directors,Core technical personnel,Director of the Research Institute
  • 1.50M
  • qiangguo xu
  • Independent directors
  • 119.00K
  • feng qu
  • Independent directors
  • 119.00K
  • wenyan hu
  • Independent directors
  • 119.00K
  • jifu gao
  • Independent directors
  • 119.00K
  • hua zhou
  • Board Secretary
  • 701.20K
  • leer wu
  • Securities affairs representative
  • --
  • biao liu
  • Chairman of the Supervisory Board,auditors,Core technical personnel
  • 857.70K
  • xiping qin
  • auditors
  • 119.00K
  • jianjun jiang
  • Deputy General Manager,Core technical personnel,Deputy Director of the Research Institute
  • 878.10K
  • tangqing li
  • Deputy General Manager
  • 928.40K
  • xiaohua li
  • Deputy General Manager
  • 1.17M
  • wei ding
  • Chief Financial Officer
  • 771.20K
  • ting liu
  • Core technical personnel
  • 589.80K
  • yu zhang
  • Core technical personnel
  • 295.10K
  • chengqing zhao
  • Core technical personnel
  • 783.30K
  • meilu sun
  • Employee supervisors
  • 271.70K

Analysis

Analyst Rating

No Data

Price Target

No Data

Heat List
CN
Overall
Symbol
Latest Price
%Chg